References used on this site

  1. Parker JN, Parker PM. The Official Patient's Sourcebook on Diabetic Neuropathy: A Revised and Updated Directory for the Internet Age. San Diego, CA: ICON Group International, Inc; 2002:11-22.
  2. Veves, Aristidis, et al. Endothelial Dysfunction and the Expression of Endothelial Nitric Oxide Synthetase in Diabetic Neuropathy, Vascular Disease, and Foot Ulceration. Diabetes 1998;47:457-463.
  3. Walker MJ Jr, Morris LM. Increased cutaneous sensibility in patients with diabetic neuropathy utilizing a pharmacological approach-clinical case evidence. Clinical Case Update: Vascular Disease Management. 2007;2(1):1-8.
  4. Abstracts of the 7th Annual Conference on Arteriosclerosis, Thrombosis, and Vascular Biology. Oral Presentations. Arterioscler Thromb Vasc Biol. 2006; 26: e43-e52.
  5. Argoff CE et al. Diabetic Peripheral Neuropathic Pain: Clinical and Quality-of-Life Issues. Mayo Clinic Proceedings April 2006;81(4 suppl):S3-S11.
  6. Wald D, et al. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202.
  7. Klerk M, et al. MTHFR C->T Polymorphism and Risk of Coronary Heart Disease: A Meta-analysis. JAMA 2002;288:2023-2030.
  8. The Diabetic Newsletter courtesy of NIDDK 2005.
  9. Verhaar MC, et al. 5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia. Circulation 1998;97:237-241.
  10. Yaqub B, et al. Effects of methylcobalamin on diabetic neuropathy. Clinical Neurology and Neurology 1992;94:105-111.
  11. Vascular Disease Management 2005;2(Suppl 6):1S-9S.
  12. Woo KS, et al. Long-term Improvement in Homocysteine Levels and Arterial Endothelial Function after 1 Year Folic Acid Supplementation. The American Journal of Medicine 2002;112:535-539.
  13. Adler AJ, et al. Lower-Extremity Ulceration in Diabetes. Diabetes Care 1999;22:1029-1035.
  14. Frykberg RG, et al. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care 1998;21:1714-1719.
  15. Romerio S. etal. Acute hyperhomocysteinemia decreases NO bioavailability in healthy adults. Atherosclerosis. 2004;176:337-344.
  16. de Bree, Angelika, et al.Effect of the methylenetetrahydrofolate reductase 677C->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am J Clin Nutr 2003; 77:687-93.
  17. Eikelboom JW. Etal. Homocysteine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence. Ann Intern Med. 1999;131;363375.
  18. Manilow, Rene M. et al. Homocyst(e)ine, Diet, and Cardiovascular Diseases A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association. AHA Nutrition Committee. January 1999. 178-182.
  19. Pocket Guide to Prevention of Coronary Heart Disease. International Task Force for Prevention of Coronary Heart Disease. January 2003.
  20. O'Callaghan P, Ward D, Graham I. Homocysteine and Cardiovascular Disease: Time to Routinely Screen and Treat? Br J Cardiol 2003; 10:115-117.
  21. Stranger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M. D.A.CH.-Liga Homocystein (German, Austrian, and Swiss Homocysteine Society) Consensus Paper on the Rational Clinical Use of Homocysteine, Folic Acid, and B Vitamins in Cardiovascular and Thrombotic Diseases: Guidelines and Recommendations. CCLM; 2003, in press.
  22. Kuan YM, et al. Homocysteine: an aetiological contributor to peripheral vascular arterial disease. ANZ J Surg. 2002 Sept; 72 (9): 668-671.
  23. Hoogeveen EK, et al. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study. Circulation, 2000 Apr 4; 101 (13): 1506-1511.
  24. Rassoul F, et al. Plasma Homocysteine and Lipoprotein Profile in Patients with Peripheral Arterial Occlusive Disease. Angiology 2000; 51: 189/186.
  25. Ambrosch A. etal. Relation between homocysteinemia and diabetic neuropathy in patients with Type 2 diabetes mellitus. Diabet Med. 2001;18:185-192.
  26. Boykin JV etal. Homocyteine - A Stealth Mediator of Impaired Wound Healing: A Preliminary Study. Wounds 2006;18(4):101-116.
  27. Boykin, JV. Ischemic vascular disease, nitric oxide deficiency, and impaired wound healing. Vascular Disease Management. 2006;3(Suppl A):2-11.